Related Experiment Video
Updated: Jul 16, 2026

Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Structural insight into substrate specificity of phosphodiesterase 10
Huanchen Wang1, Yudong Liu, Jing Hou
1Department of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7260, USA.
This study reveals how phosphodiesterases (PDEs) distinguish between cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Structural insights show PDE10A2 binds both substrates in a syn configuration, with specificity arising from varied interactions and conformations.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Pharmacology
Background:
- Phosphodiesterases (PDEs) are crucial enzymes that regulate intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).
- The precise mechanisms by which different PDE families achieve selectivity for either cAMP or cGMP remain largely unelucidated.
- Understanding substrate specificity is key to developing targeted PDE inhibitors for therapeutic applications.
Purpose of the Study:
- To elucidate the structural basis of substrate recognition and specificity in phosphodiesterase 10A (PDE10A).
- To investigate the binding modes of cAMP and cGMP within the active site of PDE10A2.
Main Methods:
- X-ray crystallography was employed to determine the structures of PDE10A2 catalytic domain mutants (D674A and D564N).
- Complex structures were solved with both cAMP and cGMP bound to the enzyme.
- Sequence alignment and analysis of conserved residues were performed across different PDE families.
Main Results:
- Crystal structures revealed that both cAMP and cGMP bind to the PDE10A2 active site in a syn configuration, but with distinct orientations and interactions.
- Enzyme products, AMP and GMP, adopt an anti configuration and interact with divalent metal ions, unlike the substrates.
- The invariant glutamine residue's conformation is fixed, suggesting it does not directly mediate substrate selection.
- Sequence analysis identified a variable pocket across PDE families, correlating with substrate specificity.
Conclusions:
- The syn configuration of cAMP and cGMP represents the genuine substrate binding mode for PDE10.
- Substrate specificity in PDE10A is determined by differential interactions and conformational states of the bound substrates within the active site.
- Variations in amino acid residues forming a potential pocket across PDE families dictate substrate specificity, offering a generalizable model for PDE selectivity.
More Related Videos
Related Concept Videos
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Phosphodiester Linkages
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzyme Inhibition

